Macular Degeneration Archives

Autoconjunctival Graft Compromise After Pterygium Surgery in a Patient Receiving Intravitreal Anti-Vascular Endothelial Growth Factor Injections.

Oct 18, 2016 | Macular Degeneration

Abstract: To report on a case of autoconjunctival graft compromise after pterygium surgery in a patient on long-term anti-vascular endothelial growth factor (anti-VEGF) therapy, due to the deleterious effects of anti-VEGF agents on ocular wound healing. A white female...

Exacerbation of macular oedema associated with hyperbaric oxygen therapy.

Dec 17, 2015 | Macular Degeneration

Abstract: Yonekawa, Hypes, Abbey, Williams, Wolfe, , , , (2016). Exacerbation of macular oedema associated with hyperbaric oxygen therapy. Clinical & experimental ophthalmology, 2016 Sep;44(7):625-626. https://www.ncbi.nlm.nih.gov/pubmed/26844686

Hyperbaric oxygen therapy for choroidal neovascularization: a pilot study.

Jun 23, 2015 | Macular Degeneration

Abstract: Choroidal neovascularization (CNV) is one of the leading causes of blindness worldwide and affects patients with wet age-related macular degeneration (AMD). Its natural course may lead to impaired central vision and macular fibrosis. Even VEGF blockade,...

Hyperbaric oxygen therapy and the possibility of ocular complications or contraindications.

May 3, 2014 | Macular Degeneration

Abstract: Hyperbaric oxygen therapy increases oxygen pressure and the concentration of reactive oxygen species in blood and tissues. Increased oxygen pressure may be beneficial in some diseases, such as in the treatment of diabetic leg ulcers and diabetic retinopathy;...

Age-related macular degeneration and hyperbaric oxygen.

Oct 9, 2010 | Macular Degeneration

Abstract: Worth, Carver, , , , , , , (). Age-related macular degeneration and hyperbaric oxygen. Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc, ;37(5):375; author reply...

Hyperbaric oxygen therapy and age-related macular degeneration.

May 14, 2010 | Macular Degeneration

Abstract: Age-related macular degeneration (AMD) is a significant cause of visual loss in the United States and Western Europe. As the population ages, the prevalence rate of advanced AMD is expected to double by 2030. A one-hour session of hyperbaric oxygen therapy...

[Medical treatment of macular edema].

Sep 20, 2007 | Macular Degeneration

Abstract: Macular edema was first described more than a century ago, and its medical treatment has made great progress thanks to recent pharmacological advances. Administration is topical, local (peri- or intraocular), or systemic. Nonsteroidal anti-inflammatory...

Resolution of diabetic macular oedema following high altitude exercise.

Nov 7, 2006 | Macular Degeneration

Abstract: Averous, Erginay, Timsit, Haouchine, Gaudric, Massin, , , (2006). Resolution of diabetic macular oedema following high altitude exercise. Acta ophthalmologica Scandinavica, 2006 Dec;84(6):830-1. https://www.ncbi.nlm.nih.gov/pubmed/17083552

Promising visual improvement of cystoid macular oedema by hyperbaric oxygen therapy.

Aug 5, 2004 | Macular Degeneration

Abstract: Jansen, Nielsen, , , , , , , (2004). Promising visual improvement of cystoid macular oedema by hyperbaric oxygen therapy. Acta ophthalmologica Scandinavica, 2004 Aug;82(4):485-6. https://www.ncbi.nlm.nih.gov/pubmed/15291949

[Criswick-Schepens syndrome — familial exudative vitreoretinopathy. Report of six cases in two consanguineous families].

Apr 7, 2004 | Macular Degeneration

Abstract: Familial exudative vitreoretinopathy is a hereditary, bilaterally progressive formation of a vitreoretinal membrane. It usually occurs in full-term newborns without previous treatment with hyperbaric oxygen. In this report, we present six cases of this...